(Q46157359)

English

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study

scientific article published on 19 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

0 references

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Stefan Blankenberg

13

object named as

Stefan Blankenberg

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

Renate B. Schnabel

14

object named as

Renate B Schnabel

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

5

object named as

Philipp S Wild

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

3

object named as

Edith Lubos

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

Christoph Bickel

7

object named as

Christoph Bickel

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

Hans-Jürgen Rupprecht

6

object named as

Hans J Rupprecht

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

4

object named as

Viviane Nicaud

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

12

object named as

Thomas F Münzel

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

11

object named as

Laurence Tiret

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

9

object named as

Dirk Peetz

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

1

object named as

Till Keller

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

Stergios Tzikas

8

object named as

Stergios Tzikas

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

author name string

Claudia Martina Messow

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

Karl J Lackner

10

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

publication date

19 January 2009

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

European Heart Journal

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

30

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

314-320

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

A population-based study of the incidence and outcomes of diagnosed chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Chronic kidney disease: effects on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Cystatin C and the risk of death and cardiovascular events among elderly persons

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Serum cystatin C concentration as a marker of renal dysfunction in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Impact of renal dysfunction on 1-year mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Renal disease in cardiovascular disorders: an underrecognized problem

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

Applicability of estimated glomerular filtration rate in stratifying chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

How to estimate GFR-serum creatinine, serum cystatin C or equations?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN598

21 January 2018

N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1161/HY0102.100537

Identifiers

10.1093/EURHEARTJ/EHN598

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19153178

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46157359&oldid=2095273197"